Maria Jesus
Peñarrubia Ponce
Hospital Universitario Pío del Río Hortega
Valladolid, EspañaHospital Universitario Pío del Río Hortega -ko ikertzaileekin lankidetzan egindako argitalpenak (20)
2024
-
COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study
Journal of Infection and Public Health, Vol. 17, Núm. 6, pp. 939-946
2020
-
Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia
European Journal of Haematology, Vol. 104, Núm. 3, pp. 259-270
2018
-
Polymorphisms in receptors involved in opsonic and nonopsonic phagocytosis, and correlation with risk of infection in oncohematology patients
Infection and Immunity, Vol. 86, Núm. 12
2017
-
Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice
International Journal of Hematology, Vol. 106, Núm. 4, pp. 508-516
2016
-
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice
European Journal of Haematology, Vol. 97, Núm. 3, pp. 297-302
2015
-
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
American Journal of Hematology, Vol. 90, Núm. 3, pp. E40-E43
2010
-
Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients
Haematologica, Vol. 95, Núm. 5, pp. 745-751
2009
-
Efficacy and safety of Liposomal cytarabine in lymphoma Patients with central nervous system involvement from lymphoma
Cancer, Vol. 115, Núm. 9, pp. 1892-1898
-
Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion
Leukemia Research
-
High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics
Leukemia Research, Vol. 33, Núm. 12, pp. 1706-1709
-
Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide
Leukemia and Lymphoma, Vol. 50, Núm. 8, pp. 1283-1289
-
Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia
Blood, Vol. 114, Núm. 1, pp. 148-152
2008
-
The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia
Haematologica, Vol. 93, Núm. 12, pp. 1797-1805
2006
-
Diagnosis of a primary testicular lymphoma by echography and magnetic resonance imaging
Clinical and Translational Oncology, Vol. 8, Núm. 6, pp. 456-458
-
Oral anticoagulant treatment: Risk factors involved in 500 intracranial hemorrhages
Journal of Thrombosis and Thrombolysis, Vol. 22, Núm. 2, pp. 113-120
2004
-
Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction
Circulation Research, Vol. 95, Núm. 7, pp. 742-748
-
Intracoronary stem cell transplantation in acute myocardial infarction
Revista Espanola de Cardiologia, Vol. 57, Núm. 3, pp. 201-208
2003
-
A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: No differences in cytogenetic responses
Annals of Hematology, Vol. 82, Núm. 12, pp. 750-758
-
Emphysematous gastritis and severe aplastic anemia
Hematology Journal, Vol. 4, Núm. 1, pp. 82-84
-
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow
Blood, Vol. 102, Núm. 8, pp. 3043-3051